| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.
|
Ann Surg
|
2002
|
8.30
|
|
2
|
Actual 10-year survival after resection of colorectal liver metastases defines cure.
|
J Clin Oncol
|
2007
|
4.95
|
|
3
|
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.
|
Ann Surg
|
2006
|
3.34
|
|
4
|
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
|
Ann Surg
|
2008
|
3.16
|
|
5
|
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.
|
Ann Surg
|
2003
|
3.14
|
|
6
|
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
|
Cancer
|
2003
|
2.96
|
|
7
|
Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.
|
J Gastrointest Surg
|
2003
|
2.36
|
|
8
|
Analysis of the extent of resection for adenocarcinoma of the gallbladder.
|
Ann Surg Oncol
|
2008
|
2.28
|
|
9
|
Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy.
|
Ann Surg
|
2009
|
2.27
|
|
10
|
The impact of margins on outcome after hepatic resection for colorectal metastasis.
|
Ann Surg
|
2007
|
2.23
|
|
11
|
The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion?
|
J Am Coll Surg
|
2003
|
2.20
|
|
12
|
Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma.
|
J Am Coll Surg
|
2003
|
2.09
|
|
13
|
Impact of steatosis on perioperative outcome following hepatic resection.
|
J Gastrointest Surg
|
2003
|
2.05
|
|
14
|
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.
|
J Am Coll Surg
|
2010
|
1.98
|
|
15
|
Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
|
J Am Coll Surg
|
2003
|
1.97
|
|
16
|
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
|
Ann Surg
|
2009
|
1.94
|
|
17
|
Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
|
Cancer
|
2002
|
1.85
|
|
18
|
Novel pancreaticojejunostomy with a low rate of anastomotic failure-related complications.
|
J Am Coll Surg
|
2009
|
1.82
|
|
19
|
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.
|
Ann Surg
|
2008
|
1.76
|
|
20
|
Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients.
|
Ann Surg
|
2002
|
1.75
|
|
21
|
Outcome of patients with fibrolamellar hepatocellular carcinoma.
|
Cancer
|
2006
|
1.66
|
|
22
|
Management of primary liver sarcomas.
|
Cancer
|
2007
|
1.65
|
|
23
|
Caudate hepatectomy for cancer: a single institution experience with 150 patients.
|
J Am Coll Surg
|
2005
|
1.64
|
|
24
|
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
|
J Clin Oncol
|
2006
|
1.60
|
|
25
|
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.
|
Ann Surg
|
2005
|
1.60
|
|
26
|
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer.
|
J Am Coll Surg
|
2004
|
1.58
|
|
27
|
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
|
Ann Surg
|
2011
|
1.57
|
|
28
|
Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents.
|
J Am Coll Surg
|
2007
|
1.52
|
|
29
|
Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
|
Ann Surg
|
2008
|
1.52
|
|
30
|
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
|
J Am Coll Surg
|
2007
|
1.51
|
|
31
|
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma.
|
Ann Surg
|
2005
|
1.49
|
|
32
|
Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.
|
Ann Surg Oncol
|
2008
|
1.48
|
|
33
|
Extrahepatic bile duct carcinoid tumors: malignant biliary obstruction with a good prognosis.
|
J Am Coll Surg
|
2007
|
1.46
|
|
34
|
Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
|
Ann Surg
|
2010
|
1.43
|
|
35
|
Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.
|
J Am Coll Surg
|
2007
|
1.39
|
|
36
|
Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.
|
Ann Surg
|
2008
|
1.39
|
|
37
|
Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation.
|
Ann Surg
|
2003
|
1.35
|
|
38
|
Surgical therapy for metastatic disease to the liver.
|
Annu Rev Med
|
2005
|
1.34
|
|
39
|
Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
|
J Vasc Interv Radiol
|
2008
|
1.33
|
|
40
|
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
|
Am J Surg Pathol
|
2002
|
1.29
|
|
41
|
Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management.
|
Ann Surg
|
2010
|
1.28
|
|
42
|
Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases.
|
Ann Surg Oncol
|
2010
|
1.27
|
|
43
|
Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.
|
Cancer
|
2005
|
1.26
|
|
44
|
Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment.
|
Ann Surg
|
2011
|
1.24
|
|
45
|
Polypoid lesions of the gallbladder: diagnosis and followup.
|
J Am Coll Surg
|
2009
|
1.24
|
|
46
|
An audit of results of a no-drainage practice policy after hepatectomy.
|
Am J Surg
|
2002
|
1.20
|
|
47
|
Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
|
Ann Surg Oncol
|
2008
|
1.19
|
|
48
|
Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer.
|
Ann Surg Oncol
|
2004
|
1.18
|
|
49
|
CT angiography for delineation of celiac and superior mesenteric artery variants in patients undergoing hepatobiliary and pancreatic surgery.
|
AJR Am J Roentgenol
|
2007
|
1.18
|
|
50
|
Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
|
Ann Surg Oncol
|
2006
|
1.17
|
|
51
|
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
|
J Am Coll Surg
|
2007
|
1.16
|
|
52
|
Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer.
|
J Gastrointest Surg
|
2002
|
1.15
|
|
53
|
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract.
|
J Exp Clin Cancer Res
|
2009
|
1.12
|
|
54
|
Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma.
|
J Am Coll Surg
|
2005
|
1.12
|
|
55
|
Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience.
|
J Hepatobiliary Pancreat Sci
|
2009
|
1.09
|
|
56
|
Central pancreatectomy revisited.
|
J Gastrointest Surg
|
2006
|
1.09
|
|
57
|
Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.
|
Cancer
|
2010
|
1.07
|
|
58
|
Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
|
Cancer
|
2008
|
1.07
|
|
59
|
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma.
|
HPB (Oxford)
|
2009
|
1.06
|
|
60
|
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
|
Ann Surg
|
2015
|
1.06
|
|
61
|
Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases.
|
Arch Surg
|
2004
|
1.03
|
|
62
|
Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
|
Ann Surg Oncol
|
2006
|
1.02
|
|
63
|
Differential diagnosis of proximal biliary obstruction.
|
Surgery
|
2006
|
1.01
|
|
64
|
Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation.
|
HPB (Oxford)
|
2012
|
1.00
|
|
65
|
Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.
|
Ann Surg
|
2006
|
0.99
|
|
66
|
Hepatic intraductal oncocytic papillary carcinoma.
|
Cancer
|
2002
|
0.98
|
|
67
|
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
|
Ann Surg Oncol
|
2006
|
0.98
|
|
68
|
Central hepatic resection for pediatric tumors.
|
J Pediatr Surg
|
2002
|
0.97
|
|
69
|
A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.
|
Ann Surg
|
2008
|
0.96
|
|
70
|
Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer.
|
Arch Surg
|
2007
|
0.94
|
|
71
|
Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer.
|
J Am Coll Surg
|
2009
|
0.94
|
|
72
|
Preoperative radiographic assessment of hepatic steatosis with histologic correlation.
|
J Am Coll Surg
|
2007
|
0.92
|
|
73
|
Surgery and ablative therapy for hepatocellular carcinoma.
|
J Clin Gastroenterol
|
2002
|
0.91
|
|
74
|
Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome.
|
Surg Today
|
2004
|
0.91
|
|
75
|
Adult-onset asthma and periocular xanthogranulomas in a patient with lymphoplasmacytic sclerosing pancreatitis.
|
Pancreas
|
2007
|
0.89
|
|
76
|
Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions.
|
World J Surg
|
2006
|
0.88
|
|
77
|
Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention.
|
Ann Surg Oncol
|
2008
|
0.88
|
|
78
|
Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
|
Surgery
|
2011
|
0.87
|
|
79
|
Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.
|
Ann Surg Oncol
|
2012
|
0.87
|
|
80
|
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.
|
Ann Surg Oncol
|
2011
|
0.86
|
|
81
|
Resection of recurrent ovarian or fallopian tube carcinoma involving the liver.
|
Gynecol Oncol
|
2003
|
0.85
|
|
82
|
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions.
|
HPB (Oxford)
|
2008
|
0.83
|
|
83
|
Resection of the liver.
|
J Am Coll Surg
|
2005
|
0.83
|
|
84
|
Surgical therapy for hepatocellular carcinoma.
|
Adv Surg
|
2004
|
0.80
|
|
85
|
Roux-en-Y reconstruction after pancreaticoduodenectomy.
|
Arch Surg
|
2008
|
0.80
|
|
86
|
Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.
|
Am J Clin Oncol
|
2011
|
0.80
|
|
87
|
Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases.
|
J Gastrointest Surg
|
2011
|
0.79
|
|
88
|
Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy. Autologous transfusion on hepatectomy outcome.
|
J Gastrointest Surg
|
2007
|
0.78
|
|
89
|
Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature.
|
Pancreas
|
2006
|
0.78
|
|
90
|
Malignant transformation of hepatic adenoma with recurrence after resection.
|
HPB (Oxford)
|
2002
|
0.78
|
|
91
|
Major hepatectomy at interval debulking for stage IV ovarian carcinoma: a case report.
|
Gynecol Oncol
|
2002
|
0.76
|
|
92
|
Hepatic metastasectomy in children.
|
Cancer
|
2007
|
0.75
|
|
93
|
Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy.
|
HPB (Oxford)
|
2013
|
0.75
|
|
94
|
Liver resection. State of the art.
|
Chir Ital
|
2006
|
0.75
|
|
95
|
Hepatic 'pseudotumours': right upper quadrant masses mimicking intrahepatic tumours.
|
ANZ J Surg
|
2002
|
0.75
|
|
96
|
Management of the left hepatic duct during extended right hepatectomy.
|
HPB (Oxford)
|
2002
|
0.75
|
|
97
|
Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation.
|
Arch Surg
|
2005
|
0.75
|